Gene Editing Market Research Report, By Methods (Crispr, Talen, Zfn, Antisense Technology And Others), By Applications (Plant Genetic Engineering, Animal Genetic Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User (Biotechnology, Pharmaceutical, Contract Research Organization) – Global Forecast Till 2027
ID: MRFR/LS/0236-HCR | February 2021 | Region: Global | 80 pages
Market Scenario:
Genes control heredity and provide the basic biological code to determine the specific function of cell. Cells have unique mechanism to protect themselves from attack from viruses, bacteria and fungi. Gene Editing is bimolecular method for targeted modification of DNA, including genetic materials of plants, animals and humans. In Gene Editing a DNA is inserted, deleted or replaced in the genome of an organism to treat particular diseases.
Gene Editing has been something of a revolution. It has transformed from something that is normally difficult to carry out in day to day laboratory technology. Gene Editing has generated lot of eagerness in research institutions and drug development due to its ability to change genetic mutations that may cause disease. This method helps in creating and controlling genetic information within patient cells. It is now vital in both drug discovery and diagnostics and its precision medicine that are driving growth of the market. Whereas, the restraints of the Gene Editing market is strict regulatory policies and adverse public perception related to genetic research
Figure 1- Global Gene Editing market, by methods
Source- Annual reports, Press release, White paper, Company Presentation
The global Gene Editing market is expected to grow at a CAGR of 18.30% during forecasted period 2019-2023.
Key Players
GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).
Segmentation
The global Gene Editing market is segmented on basis of methods, applications and end users. Based on methods, the market is segmented as CRISPR, TALEN, ZFN, Antisense technology and others. On the basis of application they are segmented as plant genetic engineering, animal genetic engineering, microorganism’s genetic engineering and gene therapy. On the basis of end users, the market is segmented into biotechnology, pharmaceuticals and contract research organizations.
Market Assessment
Sources- Annual reports, World Health Organization (WHO), White paper, Company Presentation
Regional Analysis
On the regional basis, the market is segmented into- America, Europe, Asia Pacific and Middle East and Africa. Due to huge development in drug discovery research, increase in number of research studies, development of biotechnology sector and many more are responsible for making US as dominating in market. Europe has always invested in advancement of technology for better treatment solutions. Asia Pacific has the highest growth rate for the life science market. Increasing government support to boost biotechnology sector for better treatment of diseases. Due to lack of technical knowledge, less development in biotechnology sector in Middle East & Africa will have limited growth in the market.
Study objectives global Gene Editing market
- To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the Gene Editing Market
- To provide insights about factors affecting the market growth.
- To analyse the Gene Editing market based on various factors- Price Analysis, Supply Chain Analysis, and Porters Five Force Analysis etc.
- To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies - America, Europe, Asia-Pacific and Middle East & Africa and their countries.
- To provide country level analysis of the market with respect to current market size and future market growth prospect.
- To provide country level analysis of the market’s segments which includes type and applications.
- To provide overview of key players and their strategic profiling in the market, comprehensively analysing their core competencies and drawing a competitive landscape of the market.
Intended Audience:
- Genome editing product manufacturers
- Genome editing product suppliers and distributors
- Venture capitalists
- Regulatory bodies
- Government research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Medical research institutes and universities
The report for global Gene Editing market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 18.30% (2018-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Methods, Applications and End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.) |
| Key Market Opportunities | Increasing government support to boost biotechnology sector for better treatment of diseases |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Gene editing is a bimolecular method for targeted modification of DNA, including the genetic materials of plants, animals, and humans. In gene editing, a DNA strand is inserted, deleted, or replaced in the genome of an organism to treat particular diseases or other specific conditions.
CRISPR holds the largest share in the Global Gene Editing Market.
Increasing awareness about the role of genetics in the development of a number of chronic diseases is the major driver for the Gene Editing Market.
The Americas is the leading regional market, driven by the U.S.
Leading players in the Gene Editing Market include Lonza, Sangamo, and Sigma-Aldrich, among others.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL GENE EDITING MARKET, BY METHODS
5.1 CRISPR
5.2 TALEN
5.3 ZFN
5.4 ANTISENSE TECHNOLOGY
5.5 AND OTHERS
6. GLOBAL GENE EDITING MARKET, BY APPLICATION
6.1 ANIMAL GENETIC ENGINEERING
6.2 PLANT GENETIC ENGINEERING
6.3 MICROORGANISMS GENETIC ENGINEERING
6.4 GENE THERAPY
7. GLOBAL GENE EDITING MARKET, BY END USER
7.1 BIOTECHNOLOGY
7.2 PHARMACEUTICAL
7.3 CONTRACT REAESARCH ORGANIZATION
8. GLOBAL GENE EDITING, BY REGION
8.1 INTRODUCTION
8.2 AMERICA
8.2.1 NORTH AMERICA
8.2.1.1 US
8.2.1.2 CANADA
8.2.2 SOUTH AMERICA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 FRANCE
8.3.1.3 UK
8.3.1.4 ITALY
8.3.1.5 SPAIN
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA-PACIFIC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 AUSTRALIA
8.4.5 REPUBLIC OF KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 UNITED ARAB EMIRATES
8.5.2 SAUDI ARABIA
8.5.3 OMAN
8.5.4 KUWAIT
8.5.5 QATAR
8.5.6 REST OF MIDDLE EAST & AFRICA
9. COMPEITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 GENSCRIPT USA INC
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 HORIZON DISCOVERY GROUP
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 LONZA GROUP LTD
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 ORIGENE TECHNOLOGIES, INC.
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 SIGMA-ALDRICH CORPORATION
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 OTHERS
11 CONCLUSION
12 KEY FINDINGS
12.1 FROM CEO’S VIEWPOINT
12.2 UNMET NEEDS OF THE MARKET
12.3 KEY COMPANIES TO WATCH
12.4 PREDICTION OF GENETICS INDUSTRY
13 APPENDIX
LIST OF TABLES
Table 1 Gene Editing Industry Synopsis, 2020-2027
Table 2 Global Gene Editing Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Gene Editing Market, by Region, 2020-2027, (USD Million)
Table 4 Global Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 5 Global Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 6 Global Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 7 Americas Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 8 Americas Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 9 Americas Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 10 North America Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 11 North America Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 12 North America Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 13 South America Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 14 South America Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 15 South America Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 16 Europe Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 17 Europe Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 18 Europe Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 19 Western Europe Gene Editing Market by Methods, 2020-2027, (USD Million)
Table 20 Western Europe Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 21 Western Europe Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 22 Eastern Europe Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 23 Eastern Europe Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 24 Eastern Europe Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 25 Asia Pacific Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 26 Asia Pacific Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 27 Asia Pacific Gene Editing Market, by End User, 2020-2027, (USD Million)
Table 28 Middle East & Africa Gene Editing Market, by Methods, 2020-2027, (USD Million)
Table 29 Middle East & Africa Gene Editing Market, by Application, 2020-2027, (USD Million)
Table 30 Middle East & Africa Gene Editing Market, by End User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Gene Editing Market
Figure 3 Segmentation Market Dynamics for Gene Editing Market
Figure 4 Global Gene Editing Market Share, by Methods, 2016
Figure 5 Global Gene Editing Market Share, by Application, 2016
Figure 6 Global Gene Editing Market Share, by End User, 2016
Figure 7 Global Gene Editing Market Share, by Region, 2016
Figure 8 Americas Gene Editing Market Share, by Country, 2016
Figure 9 Europe Gene Editing Market Share, by Country, 2016
Figure 10 Asia Pacific Gene Editing Market Share, by Country, 2016
Figure 11 Middle East & Africa Gene Editing Market Share, by Country, 2016
Figure 12 Global Gene Editing Market: Company Share Analysis, 2016 (%)